Viewing nowCombinationExpor Tablet 5/80 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
KS Pharmaceutical Co., Ltd.

MFDS item code 201309095 · Approved 2013.08.30 · Insurance code 059000040
Treatment of essential hypertension not controlled with monotherapy
This medication is used as an additional treatment for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or valsartan alone. Essential hypertension is characterized by persistently elevated blood pressure, which increases the risk of cardiovascular diseases, and this medication effectively lowers blood pressure to improve health. This treatment supports the maintenance of heart and vascular health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 80 mg. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 mg or valsartan 160 mg. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 10 mg or valsartan 160 mg, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this drug's ingredients or similar drugs, women who are pregnant or breastfeeding, and individuals with severe kidney or liver diseases or a history of certain heart conditions or angioedema should not take this medication. Individuals with low sodium or fluid in the body may experience hypotension, so it is important to check the conditions before taking and carefully monitor blood pressure changes during treatment. Patients with high potassium levels should have their blood potassium levels monitored regularly when taking this medication alongside other drugs that can increase potassium levels. Patients with renal vascular issues may experience worsening kidney function, and renal function should be checked periodically during treatment. Patients post-heart failure or myocardial infarction should closely monitor renal function changes, as this medication may not be suitable for some heart failure patients. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur. This medication may interact with other blood pressure medications, diuretics, potassium-sparing drugs, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so any other medications being taken must be reported. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid its use. Safety and efficacy in pediatric patients have not been sufficiently established, so it is not recommended for use. Overdose may result in severe hypotension or cardiac issues, so adhere strictly to dosage recommendations and consult a healthcare professional immediately if abnormal symptoms occur.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, hemoglobin reduction, hematocrit reduction, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremor, sensory loss, taste abnormalities, peripheral neuropathy, excessive muscle tension syndrome, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hypertrophy, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, hives, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness and safety of the medication.
Dark yellow circular film-coated tablet
28 tablets/box [14 tablets/Alu-Alu X 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg
Tablet · Prescription medication · Combination
KS Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.